Drug intelligence / Profile preview

cochinchina momordica seed extract

Development stage
Phase 2
Lead developer
SK Chemicals
Modality
Small Molecules
Administration
Oral
01

Overview

SK-MS10 is a standardized extract derived from the seeds of *Cochinchina momordica*, with its major active compounds being momordica saponins. It was developed by SK Chemicals (and its division SK biopharmaceuticals) for the treatment of acute and chronic gastric disorders, particularly gastritis and NSAID-induced gastric damage. Preclinical studies in rat models have demonstrated that SK-MS10 exerts gastroprotective effects by suppressing proinflammatory cytokines (such as IL-1β and TNFα), downregulating cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LOX), increasing mucus synthesis, upregulating calcitonin gene-related peptide (CGRP), and enhancing angiogenesis via VEGF expression. The compound does not significantly inhibit gastric acid secretion but may accelerate ulcer healing through multiple mechanisms including anti-inflammatory action, mucosal protection, and promotion of tissue repair[1][3][6][8].

Other names
cochinchina momordica seed extractmomordica saponins
02

Targets

ALOX5 (Arachidonate 5-lipoxygenase)Calcitonin gene-related peptide type 1 receptor

Beyond the preview

Go deeper on cochinchina momordica seed extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cochinchina momordica seed extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call